Abstract
The beta-glucuronidase-deficient mucopolysaccharidosis type VII (MPS VII) mouse accumulates partially degraded glycosaminoglycans in many cell types, including retinal pigmented epithelial (RPE) cells in the eye. This lysosomal storage in RPE cells leads to progressive retinal degeneration and reduced function as measured by flash electroretinography (ERG). The impact of AAV-mediated intraocular gene therapy on pathology and retinal function was examined in normal and MPS VII mice treated at 4 weeks of age, when lysosomal storage is evident but functional impairment is minimal in affected animals. At 16 weeks, an age at which untreated MPS VII mice have advanced histologic lesions and significantly reduced ERG amplitudes, treated eyes had nearly normal levels of beta-glucuronidase activity, preservation of cells in the outer nuclear layer of the retina, and decreased lysosomal storage within the RPE. The AAV-treated MPS VII mice also had significantly increased dark-adapted ERG amplitudes compared to untreated MPS VII mice. Although retinal function was improved, the efficacy of the treatment depended heavily on parameters related to the injection procedure, such as the injection volume, injection site, and vector dose. These d...Continue Reading
References
Jan 1, 1992·Annual Review of Biochemistry·S Kornfeld
May 1, 1990·Experimental Eye Research·L E StrammG D Aguirre
Feb 1, 1973·The Journal of Pediatrics·W S SlyD L Rimoin
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M S Sands, E H Birkenmeier
Jul 1, 1997·Gene Therapy·C JomaryS E Jones
Jan 5, 1999·Human Gene Therapy·D GrimmJ A Kleinschmidt
Feb 18, 1999·Human Gene Therapy·T M DalyM S Sands
Feb 19, 1999·Gene Therapy·G L WatsonG M Podsakoff
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·T M DalyM S Sands
Aug 24, 1999·Gene Therapy·S ZolotukhinN Muzyczka
Feb 25, 2000·Experimental Neurology·J M OgilvieJ M Lett
Jul 25, 2000·Mammalian Genome : Official Journal of the International Mammalian Genome Society·L H Pinto, C Enroth-Cugell
Oct 21, 2000·Experimental Eye Research·K K OhlemillerM S Sands
Mar 29, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·W A FrisellaM S Sands
May 30, 2001·Current Opinion in Genetics & Development·D A BessantS S Bhattacharya
Sep 26, 2001·Gene Therapy·T M DalyM S Sands
Oct 11, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·Y KamataN Azuma
Nov 16, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·F Q LiangJ Bennett
Feb 28, 2002·The EMBO Journal·G Jane FarrarPeter Humphries
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Andrew I BrooksBeverly L Davidson
Jul 20, 2002·Experimental Eye Research·Dean BokMatthew M LaVail
Sep 11, 2002·The Journal of Gene Medicine·Todd A DerksenBeverly L Davidson
Nov 20, 2002·The Journal of Gene Medicine·Thucanh T HoJean Bennett
Mar 7, 2003·Gene Therapy·F C SchlichtenbredeR R Ali
Apr 15, 2003·The Journal of Heredity·K NarfströmR Bragadóttir
Apr 26, 2003·Investigative Ophthalmology & Visual Science·Edward H HughesAndrew D Dick
Dec 9, 2003·Vision Research·Wei-Yong ShenP Elizabeth Rakoczy
Citations
Feb 27, 2013·Nanomedicine·Thomas F MartensKevin Braeckmans
Aug 19, 2007·Journal of Virology·Mariacarmela AlloccaAlberto Auricchio
Aug 23, 2007·PloS One·Coy D HeldermonMark S Sands
Oct 22, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jason A MetcalfKatherine P Ponder
May 26, 2011·PloS One·Lichun TianAize Kijlstra
Oct 14, 2004·European Biophysics Journal : EBJ·Y LiuA Sakanishi
Jan 17, 2007·Expert Opinion on Biological Therapy·Mariacarmela AlloccaAlberto Auricchio
Aug 31, 2007·Expert Opinion on Biological Therapy·Katherine P Ponder, Mark E Haskins
Oct 4, 2005·Expert Opinion on Biological Therapy·Ian ConstableElizabeth Rakoczy
Nov 27, 2015·Scientific Reports·Dennis Y TseSamuel M Wu
Jul 10, 2008·The Journal of Gene Medicine·Ramin Sedaghat HeratiKatherine P Ponder
Oct 10, 2007·Vision Research·Enrico M Surace, Alberto Auricchio
Oct 24, 2007·Vision Research·Ji-jing PangWilliam W Hauswirth
Dec 29, 2012·PloS One·Zongchao HanMuna I Naash
Jun 28, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Megan GriffeyMark S Sands
Dec 9, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yuli LiuKatherine Parker Ponder
Mar 21, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark S Sands, Beverly L Davidson
Feb 22, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Xiucui MaKatherine P Ponder
Apr 29, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Samuel G JacobsonWilliam W Hauswirth
Jan 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gumei LiuBeverly L Davidson
Jan 31, 2017·Human Gene Therapy·Diane GolebiowskiMiguel Sena-Esteves
Apr 11, 2008·Gene Therapy·I E AlexanderJ Christodoulou
Jul 14, 2006·Gene Therapy·J W B BainbridgeR R Ali
Jul 1, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Adeline A Lau, Kim M Hemsley
Feb 20, 2021·Molecular Genetics and Metabolism Reports·Sean C DevanneyCoy D Heldermon
Mar 1, 2021·The American Journal of Pathology·Rubens P HommeMahavir Singh
May 1, 2021·Biomolecules·Giulia MassaroAhad A Rahim
May 17, 2021·The FEBS Journal·Daniela IntartagliaIvan Conte